Complex Treatment of Cows With Rusterholz Ulcers Using Adipose-Derived Mesenchymal Stem Cells

Abstract

The use of adipose-derived mesenchymal stem cells (MSC AT) in treatment of animals with Rustergolz ulcer is determined by the anti-inflammatory properties of these cells, their ability to increase angiogenesis and stimulate internal progenitor cells to regenerate tissue functions. These properties allow to reduce the healing time of ulcerative lesions of the hooves in cows, therefore it is advisable to use a treatment regimen with the use of mesenchymal stem cells.